ACTILYSE

This brand name is authorized in the following countries: Austria Brazil Cyprus Ecuador Estonia Spain Finland France Hong Kong Ireland Lithuania Malta Netherlands New Zealand Poland Romania Singapore Tunisia Turkey United Kingdom South Africa

Active ingredients

The drug ACTILYSE contains one active pharmaceutical ingredient (API):

1 Alteplase

UNII 1RXS4UE564 - ALTEPLASE

Alteplase is a recombinant human tissue-type plasminogen activator, a glycoprotein, which activates plasminogen directly to plasmin. Once bound to fibrin, it is activated, inducing the conversion of plasminogen to plasmin leading to the dissolution of the fibrin clot.

Read about Alteplase

Medication package inserts

Below package inserts are available for further reading:

ACTILYSE Powder and solvent for solution

Medicines & Healthcare Products Regulatory Agency (GB)

Summary of Product Characteristics (SPC)

ACTILYSE

Medicines & Healthcare Products Regulatory Agency (GB)

Summary of Product Characteristics (SPC)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

B01AD02

Alteplase

B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AD Enzymes

Discover more medicines within B01AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Câmara de Regulação do Mercado de Medicamentos

Identifier(s): 504500101153319, 504512030018303, 504512030018403

Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

Identifier(s): 29776-05-11

Ravimiamet

Identifier(s): 1004128, 1700109, 1885383

Centro de información online de medicamentos de la AEMPS

Identifier(s): 59494

Lääkealan turvallisuus- ja kehittämiskeskus

Identifier(s): 387675, 404491, 404533

Base de données publique des médicaments

Identifier(s): 63617876, 67177673

Medicines & Healthcare Products Regulatory Agency

Identifier(s): 344939, 48386, 48398, 48453

Department of Health Drug Office

Identifier(s): 30511, 37894

Valstybinė vaistų kontrolės tarnyba

Identifier(s): 1007453, 1061418, 1061419

Medicines Authority

Identifier(s): MA211/00901, MA211/00902, MA211/00903

Z-Index G-Standaard

Identifier(s): 13250949, 13733370

Z-Index G-Standaard, PRK

Identifier(s): 25747, 36870

Medicines and Medical Devices Safety Authority

Identifier(s): 13161, 4765, 4766, 4767

Rejestru Produktów Leczniczych

Identifier(s): 100002579, 100002585, 100002622

Agenția Națională a Medicamentului și a Dispozitivelor Medicale

Identifier(s): W00257001

Health Sciences Authority

Identifier(s): 02340P

Direction de la Pharmacie et du Médicament

Identifier(s): 5253111H, 5253112H, 5253113H

İlaç ve Tıbbi Cihaz Kurumu

Identifier(s): 8699693790026, 8699693790033, 8699693790040

Health Products Regulatory Authority

Identifier(s): U/31/229

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.